- Cell therapy
- Gene therapy
- Non-viral vector
- Cell transfection
- CAR-T cells
As France's leading biocluster, Genopole is an incubator for cutting-edge projects in biotechnology. Located in the city of Évry, just south of Paris, Genopole provides a unique environment for scientists and entrepreneurs seeking to advance research and innovation.Discover >
Genopole accompanies researchers, postdocs and start-up entrepreneurs through all the phases of their projects to ensure the best possible conditions for business development.Discover >
Every day, at Genopole, researchers, entrepreneurs and students cross paths, share ideas and unite forces in a veritable melting pot for innovation.Discover >
Giving wings to research and empowering employment in our community are cornerstones of Genopole's mission. Catch up on recent scientific advances, the accomplishments of our biotech actors and the events that enliven the biocluster.Discover >
We develop an in vitro manufactured targeted DNA vector to improve the efficiency of therapeutic cell transfection and to reduce the cost of gene-based therapies.
Fabmid has been incorporated in 2020 with the aim of providing novel skills and experience in the development of cell & gene therapies.
Andrey PICHUGIN (PhD, former leader of a public research lab and Founder of Fabmid SAS) developed a method to produce the first circular vector DNA molecules covalently bound with delivery vehicles of choice that target the vector to cellular nucleus.
DESCRIPTION OF THE PRODUCTS / SERVICES / TECHNOLOGY
Fabmid SAS develops safe and efficient solutions for the growing markets of cell & gene therapies. The company aims to ensure the efficient production of CAR-T-cells for helping millions of patients heal from solid and blood cancers.
Fabmid’s products: (1) circular DNA molecules covalently bound with aptamers for targeted vector delivery into cell nucleus and (2) technological platform for the vector production.
Our competitive advantages:
A cutting-edge technology for numerous applications, a very large market and a complementary team.
A robust technology, highly valuable for clinical application and scalable for industrial production.
In same field
Activity of research, sale, production, distribution and marketing of all unregulated food and agri-food products.Discover
Standing Ovation is developing the production of casein via precision fermentation to enable non-animal-derived cheese and milk substitutes.Discover
STH BIOTECH is developing an innovative cannabis-based process for the reliable and sustainable production of active compounds for the well-being and healthcare sectors.Discover
Synovance has developed a revolutionary synthetic genomics platform for the conception of robust industrial bioproduction strains.Discover
Production as a service (PaaS) platform capable of producing recombinant proteins & enzymes cheaper and on a scale.Discover
Altar is a specialist in the conception and operation of automated fluidic continuous culture systems for adaptive laboratory evolution and the development of microbial strains for industry.Discover
YposKesi is the first French company to develop and manufacture gene and cell therapy products for rare diseases.Discover
WatchFrog markets in vivo biotechnological solutions for environmental risk assessment and the evaluation of the therapeutic, toxic or pollutant potential of all types of chemical, cosmetic or pharmaceutical compounds.Discover
Pharming specializes in the production of recombinant proteins in transgenic rabbit milk.Discover
Glowee is a cleantech startup developing a disruptive lighting technology based on bioluminescence (the natural light-producing property of certain living organisms).Discover
Global Bioenergies is developing a process to convert renewable resources into hydrocarbons through fermentation.Discover
Abolis develops custom-order microorganisms able to produce molecules of interest via fermentation for the health, nutrition, chemistry and cosmetics sectors.Discover